Live Breaking News & Updates on Angiotensin Converting|Page 14

Stay updated with breaking news from Angiotensin converting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Two common blood pressure drugs are not tied to increased risk of COVID-19


Two common blood pressure drugs are not tied to increased risk of COVID-19
Research published in the peer-reviewed journal
The Lancet Digital Health and co-led by a UCLA Fielding School of Public Health faculty member has found that two widely used types of blood pressure drugs are not tied to an increased risk of COVID-19 infection or complications.
The international team co-led by Dr. Marc Suchard, UCLA Fielding School professor of biostatistics, found that there was no increased risk of COVID-19 diagnosis, hospitalization, or subsequent complications for users of either angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs). The study, the world s largest, examined a group of more than 1.1 million patients in the United States and Spain using antihypertensives, researchers said. ....

United States , United Kingdom , Marc Suchard , George Hripcsak , Daniel Morales , Emily Henderson , Yale University , Observational Health Data Services , Columbia Department Of Biomedical Informatics , University Of Oxford , Columbia University , Fielding School Of Public Health , Lancet Digital Health , Fielding School Professor Of Biostatistics , Fielding School , Columbia Data Science Institute , University Of Dundee , Public Health , School Professor , Wellcome Trust , Columbia Department , Biomedical Informatics , Columbia Data Science , Blood Pressure , Ace Inhibitor , ஒன்றுபட்டது மாநிலங்களில் ,